Dalton M, Cheng M, Bahar I, Coleman J
Elife. 2024; 12.
PMID: 38517752
PMC: 10959523.
DOI: 10.7554/eLife.91973.
Alwindi M, Bizanti A
Heliyon. 2023; 9(11):e22413.
PMID: 38034713
PMC: 10687066.
DOI: 10.1016/j.heliyon.2023.e22413.
Maneu V, Borges R, Gandia L, Garcia A
Pflugers Arch. 2023; 475(6):667-690.
PMID: 36884064
PMC: 10185644.
DOI: 10.1007/s00424-023-02793-0.
Sulzer D, Cragg S, Rice M
Basal Ganglia. 2016; 6(3):123-148.
PMID: 27141430
PMC: 4850498.
DOI: 10.1016/j.baga.2016.02.001.
Hillhouse T, Porter J
Exp Clin Psychopharmacol. 2015; 23(1):1-21.
PMID: 25643025
PMC: 4428540.
DOI: 10.1037/a0038550.
A new VGLUT-specific potent inhibitor: pharmacophore of Brilliant Yellow.
Tamura Y, Ogita K, Ueda T
Neurochem Res. 2013; 39(1):117-28.
PMID: 24248859
PMC: 4025951.
DOI: 10.1007/s11064-013-1196-8.
How addictive drugs disrupt presynaptic dopamine neurotransmission.
Sulzer D
Neuron. 2011; 69(4):628-49.
PMID: 21338876
PMC: 3065181.
DOI: 10.1016/j.neuron.2011.02.010.
VMAT2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse.
Eiden L, Weihe E
Ann N Y Acad Sci. 2011; 1216:86-98.
PMID: 21272013
PMC: 4183197.
DOI: 10.1111/j.1749-6632.2010.05906.x.
Reserpine-induced reduction in norepinephrine transporter function requires catecholamine storage vesicles.
Mandela P, Chandley M, Xu Y, Zhu M, Ordway G
Neurochem Int. 2010; 56(6-7):760-7.
PMID: 20176067
PMC: 2859979.
DOI: 10.1016/j.neuint.2010.02.011.
Vesicular monoamine transporters: structure-function, pharmacology, and medicinal chemistry.
Wimalasena K
Med Res Rev. 2010; 31(4):483-519.
PMID: 20135628
PMC: 3019297.
DOI: 10.1002/med.20187.
A closer look at amphetamine-induced reverse transport and trafficking of the dopamine and norepinephrine transporters.
Robertson S, Matthies H, Galli A
Mol Neurobiol. 2009; 39(2):73-80.
PMID: 19199083
PMC: 2729543.
DOI: 10.1007/s12035-009-8053-4.
Effect of reserpine and monoamine oxidase inhibition on the uptake and subcellular distribution of h-noradrenaline.
Stitzel R, Lundborg P
Br J Pharmacol Chemother. 2008; 29(1):99-104.
PMID: 19108245
PMC: 1557183.
DOI: 10.1111/j.1476-5381.1967.tb01943.x.
A journey from mammals to yeast with vacuolar H+-ATPase (V-ATPase).
Nelson N
J Bioenerg Biomembr. 2003; 35(4):281-9.
PMID: 14635774
DOI: 10.1023/a:1025768529677.
THE ADENOSINE-TRIPHOSPHATASE ACTIVITY OF ADRENAL CHROMAFFIN GRANULES.
Banks P
Biochem J. 1965; 95:490-6.
PMID: 14340099
PMC: 1214348.
DOI: 10.1042/bj0950490.
Plausible molecular mechanism for activation by fumarate and electron transfer of the dopamine beta-mono-oxygenase reaction.
Wimalasena D, Jayatillake S, Haines D, Wimalasena K
Biochem J. 2002; 367(Pt 1):77-85.
PMID: 12038965
PMC: 1222850.
DOI: 10.1042/BJ20020216.
Bioenergetics of neurotransmitter transport.
Rudnick G
J Bioenerg Biomembr. 1998; 30(2):173-85.
PMID: 9672239
DOI: 10.1023/a:1020573325823.
An in vivo microdialysis study of striatal 6-[18F]fluoro-L-m-tyrosine metabolism.
Jordan S, Bankiewicz K, Eberling J, VanBrocklin H, ONeil J, Jagust W
Neurochem Res. 1998; 23(4):513-7.
PMID: 9566585
DOI: 10.1023/a:1022478417383.
Proton-dependent multidrug efflux systems.
Paulsen I, Brown M, Skurray R
Microbiol Rev. 1996; 60(4):575-608.
PMID: 8987357
PMC: 239457.
DOI: 10.1128/mr.60.4.575-608.1996.
Expression and regulation of a vesicular monoamine transporter in rat stomach: a putative histamine transporter.
Dimaline R, Struthers J
J Physiol. 1996; 490 ( Pt 1):249-56.
PMID: 8745292
PMC: 1158661.
DOI: 10.1113/jphysiol.1996.sp021140.
The transcriptional regulation of the preproenkephalin gene.
Weisinger G
Biochem J. 1995; 307 ( Pt 3):617-29.
PMID: 7741689
PMC: 1136696.
DOI: 10.1042/bj3070617.
